Resources: Page 437

Interpretation error rate in screening US comparable to mammo, MRI
By Kate Madden Yee
Sunday, November 27 | 11:05 a.m.-11:15 a.m. | SSA01-03 | Arie Crown TheaterIn this scientific paper presentation, University of Pittsburgh researchers will discuss how interpretation errors in screening ultrasound are similar in frequency to interpretation errors in mammography and MRI.
November 8, 2011
BI-RADS 3 lesions common on screening US
By Kate Madden Yee
Sunday, November 27 | 10:55 a.m.-11:05 a.m. | SSA01-02 | Arie Crown TheaterBI-RADS 3 lesions are seen in nearly 20% of participants after three rounds of screening ultrasound, but they are rarely malignant, according to researchers from Southwoods Imaging Center in Youngstown, OH.
November 8, 2011
PeerVue to launch free VR at RSNA
By AuntMinnie.com staff writers
Software developer PeerVue will debut free integrated voice recognition (VR) for its Qualitative Intelligence and Communications System at the upcoming RSNA 2011 meeting in Chicago.
November 7, 2011
ORS to introduce 3D thin-client software
By AuntMinnie.com staff writers
Advanced visualization software developer Object Research Systems (ORS) plans to demonstrate a thin-client version of its ORS Visual enterprise-wide 3D software architecture at the RSNA 2011 meeting in Chicago.
November 7, 2011
Kjaya to debut cloud-based image sharing
By AuntMinnie.com staff writers
Medical graphics computing technology firm Kjaya Medical will introduce a new cloud-based image sharing app, called iShareScan.com, at the RSNA 2011 meeting in Chicago.
November 7, 2011
Road to RSNA 2011: Molecular Imaging Preview
By Wayne Forrest
At this year's annual RSNA meeting, the advance of hybrid imaging and the development of new imaging agents are expected to be among the most intriguing developments in molecular imaging and nuclear medicine in Chicago.
November 7, 2011
Road to RSNA 2011: Molecular Imaging Preview
MRI protocol developed for attenuation correction in PET/MRI for head and neck cancer
By Wayne Forrest
Wednesday, November 30 | 10:50 a.m.-11:00 a.m. | SSK13-03 | Room S505ABGerman researchers are developing a potential MRI protocol for use in a PET/MRI system to handle whole-body attenuation correction and diagnostic sequences for staging head and neck cancer patients.
November 7, 2011
FDG-PET/CT study helps detect brain changes from chemotherapy
By Wayne Forrest
Tuesday, November 29 | 3:50 p.m.-4:00 p.m. | SSJ19-06 | Room S505ABFDG-PET/CT may be a beneficial diagnostic tool to document cognitive decline, or "chemo brain," in breast cancer patients receiving chemotherapy, according to a study from West Virginia University Hospitals.
November 7, 2011
FDG-PET metabolic parameters help differentiate severity of brain tumors
By Wayne Forrest
Tuesday, November 29 | 3:20 p.m.-3:30 p.m. | SSJ19-03 | Room S505ABIn this presentation, researchers will discuss how standardized uptake values and glucose metabolic rates can help differentiate between tumors and benign lesions when evaluating patients with central nervous system lesions with FDG-PET.
November 7, 2011
Fused PET/MRI tops MR spectroscopy in brain tumor recurrence
By Wayne Forrest
Tuesday, November 29 | 3:00 p.m.-3:10 p.m. | SSJ19-01 | Room S505ABA study from the University of California, San Diego has found fused FDG-PET/MRI to be more sensitive, specific, and accurate than MR spectroscopy in detecting the recurrence of primary and metastatic brain tumors in patients with a history of grade III or IV brain tumors.
November 7, 2011
Choline-PET/CT in recurrent prostate cancer cases could alter therapy
By Wayne Forrest
Tuesday, November 29 | 11:50 a.m.-12:00 p.m. | SSG12-09 | Room S505ABCholine-PET/CT can greatly affect therapy management for recurrent prostate cancer patients and should be considered for restaging, according to a new study by Swiss researchers.
November 7, 2011
Novel tracer shows early promise for brain tumor imaging
By Wayne Forrest
Tuesday, November 29 | 11:40 a.m.-11:50 a.m. | SSG08-08 | Room S504CDIn this scientific paper presentation, researchers from Washington University School of Medicine will present their work on a novel synthesized tracer that so far has shown promising tumor imaging properties in the potential to complement MRI for evaluating patients with primary and metastatic brain tumors.
November 7, 2011
Previous Page
Page 437 of 726
Next Page